• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Fresenius

DaVita, Fresenius slide on Trump threat to overhaul dialysis market

July 9, 2019 By Brad Perriello

Shares of dialysis providers DaVita Healthcare (NYSE:DVA) and Fresenius (NYSE:FMS) took a hit today after a report surfaced that the Trump administration is readying an overhaul of the kidney treatment market. The president plans to issue an executive order tomorrow that would seek to incentivize kidney transplants and home hemodialysis in a bid to lower the […]

Filed Under: Dialysis, Featured, Wall Street Beat Tagged With: DaVita Inc., Dept. of Health & Human Services (HHS), Fresenius

Fresenius invests in BioIntelliSense

July 9, 2019 By Danielle Kirsh

Fresenius Medical Care (NYSE:FMS; ETR:FRE) today announced an investment in BioIntelliSense for an undisclosed amount. Denver-based BioIntelliSense is developing a medical-grade data services platform for continuous remote health monitoring, predictive analytics and algorithmic clinical insights. Through the agreement, Fresenius will use the advanced analytics and artificial intelligence to develop medical wearables for clinical pathways that allow […]

Filed Under: Diagnostics, Dialysis Tagged With: Fresenius, Fresenius Medical Care

Fresenius OKs $748m stock buyback

June 21, 2019 By Brad Perriello

Fresenius (NYSE:FMS) said last week that its board authorized a stock buyback worth up to €660 million, or just more than 3% of its total shares. The one-year authorization to repurchase up to 12 million shares is worth about $748 million; on the day of any trades the Bad Homburg, Germany-based renal care giant can’t miss that […]

Filed Under: Business/Financial News, Dialysis, Wall Street Beat Tagged With: Fresenius

S&P upgrades Fresenius Medical

May 28, 2019 By Fink Densford

Fresenius Medical Care (NYSE:FMS; ETR:FRE) said last Thursday that Standard & Poor’s upgraded its corporate credit rating to BBB. The Bad Homburg, Germany-based company said that S&P gave them a BBB rating with a stable outlook from BBB- with a positive outlook. Fresenius said that it is rated as investment grade by the three leading rating agencies […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Fresenius

‘Berkmorgazon’ health play Haven COO Stoddard steps away | Personnel Moves – May 17, 2019

May 17, 2019 By Fink Densford

Healthcare joint venture Haven, started by Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan, has lost its COO Jack Stoddard at just nine months post-hiring, according to a CNBC report. The former digital health general manager for Comcast told the news channel that he is departing the healthcare play due to personal reasons, including the distance between […]

Filed Under: Business/Financial News Tagged With: Amazon, avitamedical, Berkshire Hathaway, Boston Scientific, Cantel Medical Corp., Fresenius, gerresheimer, haven, JP Morgan Chase, oculartherapeutix, proteor, Pulmatrix Inc.

Fresenius posts Street-beating Q1 earnings

May 3, 2019 By Fink Densford

Shares in Fresenius Medical Care (NYSE:FMS; ETR:FRE) rose slightly today after the dialysis-focused device maker beat expectations on Wall Street with its first quarter earnings release. The Bad Homburg, Germany-based company posted profits of $303.2 million, or 99¢ per share, on sales of approximately $4.62 billion for the three months ended March 31, seeing the bottom […]

Filed Under: Business/Financial News, Dialysis, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Fresenius

FTC grants final approval for Fresenius’s $2B buyout of NxStage

April 10, 2019 By Fink Densford

The U.S. Federal Trade Commission said yesterday that it granted a final order of approval to Fresenius Medical Care (NYSE:FMS; ETR:FRE) for its $2 billion acquisition of NxStage Medical. The approval came with a caveat that the companies divest their assets and rights to research, develop, manufacture, market and sell NxStage’s bloodline tubing sets intended for use […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Fresenius, NxStage Medical Inc.

SEC details Fresenius’ $231m FCPA settlement

April 3, 2019 By Fink Densford

Updated to include a response from Fresenius The U.S. Securities and Exchange Commission today detailed the more than $231 million that Fresenius Medical Care (NYSE:FMS; ETR:FRE) agreed to pay to resolve self-reported violations of the Foreign Corrupt Practices Act. In its release, the SEC said that it found that Germany-based Fresenius engaged in misconduct in Saudi […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Fresenius

ConvaTec taps Bitar as CEO | Personnel Moves – March 26, 2019

March 26, 2019 By Fink Densford

ConvaTec (LON:CTEC) said today it tapped Karim Bitar as its new CEO, set to take the position on September 30. Prior to joining the U.K.-based medtech company, Bitar served as CEO of agricultural biotech company Genus, holding the corner office position for approximately eight years. Before his time with Genus, Bitar spent 15 years in various […]

Filed Under: Business/Financial News, Featured Tagged With: Baxter, Cantel Medical Corp., ConvaTec, Fresenius, Lantheus, micronsolutions, Millstone Medical Outsourcing, Monarch Medical, Pavmed, sonedo

Fresenius wins FDA breakthrough device nod for fluid management software

March 15, 2019 By Fink Densford

Fresenius (NYSE:FMS) said yesterday that it won FDA breakthrough device designation for its computer-assisted ultrafiltration control software intended to improve fluid management during hemodialysis. The Waltham, Mass.-based company said that the software is designed to work with its newer hemodialysis machines using its CLiC device. Fresenius said that with the software, it hopes to create a […]

Filed Under: Dialysis, Featured, Food & Drug Administration (FDA), Software / IT Tagged With: Fresenius

Fresenius preps $370m stock buyback

March 12, 2019 By Brad Perriello

Fresenius (NYSE:FMS) said today that it’s planning a stock buyback of up to $370 million worth of its own shares. Shareholders in the German renal care giant said its shareholders approved the roughly 6-million-share buyback in May 2016. The €330 million repurchasing plan is slated to run from today through May 10, Fresenius said. If fully […]

Filed Under: Featured, Wall Street Beat Tagged With: Fresenius, Renal

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 14
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS